In summary, treatment with ELX/TET/IVA led to a substantial and highly significant decrease of SCC in sweat test at the population level (Table 1 ), but the response of the individual patient was highly variable.
← all excerpts
Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators.
1
—
—